Salim Yusuf

Last updated

Salim Yusuf
Born (1952-11-26) 26 November 1952 (age 71)
Kottarakkara
Nationality Canadian
Alma mater
Known for President of the World Heart Federation
Awards Rhodes Scholarship
Canadian Medical Hall of Fame
Canada Gairdner Wightman Award McLaughlin medal of the Royal Society of Canada
Scientific career
Fields
Institutions
Thesis Beta adrenergic blokade in myocardial infarction  (1980)
Doctoral advisor Peter Sleight

Salim Yusuf OC FRSC (born 26 November 1952) is an Indian-born Canadian physician, the Marion W. Burke Chair in Cardiovascular Disease at McMaster University Medical School. He is a cardiologist and epidemiologist, [1] and is well known for his cardiology-related clinical trial research. [2] He also formerly served as president of the World Heart Federation. Yusuf has criticized the Dietary Guidelines for Americans and disputes the scientific consensus on dietary sodium and saturated fat intake.

Contents

Early life and education

Salim Yusuf was born in 1952 in a middle class family [2] in the town of Kottarakkara in Kerala, India, and was educated at schools in Kottarakkara, as well as Mumbai and Kochi. [3] Yusuf stated that his father compelled him to get into medicine. [2] Following a number of failed attempts, Yusuf studied medicine at St. John's Medical College in Bangalore. Yusuf recounted that he “was very aware that I was not the brightest student”, and that he "just had to work as hard as possible to keep up with my peers". [2] Yusuf later earned a DPhil at Oxford University as a Rhodes scholar. Yusuf has stated that he became interested in cardiology "partly because it was such a logical specialty and partly because it was a field in which we thought we could do much to help patients". Despite admitting that prior to studying at Oxford that he had "very little direct interest in research", at Oxford he took part in research into cardiovascular disease. [3] [2]

His doctoral thesis was titled "Beta adrenergic blockade in myocardial infarction" and his supervisor was Peter Sleight. [4]

Career

In 1984, Yusuf moved to the National Institutes of Health in the United States, where he led clinical trials that showed the value of ACE inhibitors in people with left ventricular dysfunction and the optimal use of digoxin). [1] [5] He came to the Michael G. DeGroote School of Medicine at McMaster University in 1992 as director of the cardiology division. [1] In 1999 McMaster created the Population Health Research Institute at the Hamilton Health Sciences campus of McMaster, and made Yusuf the director of the center and vice president of research at HHS. [6] [5]

From 1999 to 2004, he also held an appointment as a senior scientist at the Canadian Institutes of Health Research. [1]

One of Yusuf's most cited research studies is the INTERHEART study published in The Lancet in 2004, a case-control study regarding the risk factors of myocardial infarction (commonly known as heart attacks) with participants in 52 countries. [2] [7]

In 2011, he was the world's second-most-cited cardiology researcher, [1] and in 2020, he was the world's most-cited cardiology researcher. Yusuf's large-scale clinical trials have had a significant impact on the treatment and prevention of cardiovascular and cerebrovascular disease. [1] in particular, he has demonstrated the value of combinations of blood pressure lowering and lipid lowering with statins and of combinations of antiplatelet therapy and joint use of anticoagulants and aspirin in low doses to prevent cardiovascular disease and death.

He was a past president of the World Heart Federation 2015–2016, [8] where he initiated the Emerging Leaders Program which is now named after him. [9]

Views on saturated fat and salt intake and their relationship to cardiovascular disease

Yusuf has disputed the prevailing view in the medical community that increased consumption of saturated fat and dietary sodium causes cardiovascular disease and has questioned dietary guidelines that call for reduction in their intake. [10] In 2017, Yusuf spoke at the Cardiology Update 2017 symposium in which he disputed the saturated fat guidelines whilst admitting he is not an expert in nutrition. [11] He stated that a higher saturated fat intake is protective and eating more dietary carbohydrates is harmful. [11] Yusuf has commented that "saturated fats are not harmful, may even be slightly beneficial but there is no harm", and recommends people to consume high-fat dairy products and unprocessed red meat. [11] [12] These ideas were criticized by other medical researchers and nutritionists such as David L. Katz, who described them as "bizarre" and "misguided". [11]

Yusuf has questioned the consensus on salt and cardiovascular disease and has argued that a low sodium intake does not lower risk of cardiovascular events and mortality but increases it. [13] [14] In 2018, he co-authored a controversial paper which argued that sodium intake is associated with cardiovascular disease only in communities where mean intake is greater than 5 g/day. [14]

Honours

In 2013, Yusuf was named an Officer in the Order of Canada. [15] He is also a fellow of the Royal Society of Canada. In 2014, he was awarded the Canada Gairdner Wightman Award and was inducted into the Canadian Medical Hall of Fame. [1] In 2024, Yusuf received an honorary doctorate degree from Oxford University. [16]

Personal life

Yusuf is married to Wahida Yusuf. They have three children, two of which also studied medicine. [3]

Selected publications

Related Research Articles

<span class="mw-page-title-main">Coronary artery disease</span> Reduction of blood flow to the heart

Coronary artery disease (CAD), also called coronary heart disease (CHD), or ischemic heart disease (IHD), is a type of heart disease involving the reduction of blood flow to the cardiac muscle due to build-up of atherosclerotic plaque in the arteries of the heart. It is the most common of the cardiovascular diseases. CAD can cause stable angina, unstable angina, myocardial ischemia, and myocardial infarction.

<span class="mw-page-title-main">Fat</span> Esters of fatty acid or triglycerides

In nutrition, biology, and chemistry, fat usually means any ester of fatty acids, or a mixture of such compounds, most commonly those that occur in living beings or in food.

<span class="mw-page-title-main">Scandinavian Simvastatin Survival Study</span>

The Scandinavian Simvastatin Survival Study, was a multicentre, randomized, double-blind, placebo-controlled clinical trial, which provided the initial data that supported the use of the cholesterol-lowering drug, simvastatin, in people with a moderately raised cholesterol and coronary heart disease (CHD); that is people who had previously had a heart attack or angina. The study was sponsored by the pharmaceutical company Merck and enrolled 4,444 people from 94 centres in Scandinavia.

A saturated fat is a type of fat in which the fatty acid chains have all single bonds between the carbon atoms. A fat known as a glyceride is made of two kinds of smaller molecules: a short glycerol backbone and fatty acids that each contain a long linear or branched chain of carbon (C) atoms. Along the chain, some carbon atoms are linked by single bonds (-C-C-) and others are linked by double bonds (-C=C-). A double bond along the carbon chain can react with a pair of hydrogen atoms to change into a single -C-C- bond, with each H atom now bonded to one of the two C atoms. Glyceride fats without any carbon chain double bonds are called saturated because they are "saturated with" hydrogen atoms, having no double bonds available to react with more hydrogen.

<span class="mw-page-title-main">French paradox</span> Observation that amount heart diseases French people have is much less than is expected

The French paradox is an apparently paradoxical epidemiological observation that French people have a relatively low incidence of coronary heart disease (CHD), while having a diet relatively rich in saturated fats, in apparent contradiction to the widely held belief that the high consumption of such fats is a risk factor for CHD. The paradox is that if the thesis linking saturated fats to CHD is valid, the French ought to have a higher rate of CHD than comparable countries where the per capita consumption of such fats is lower.

<span class="mw-page-title-main">Cardiovascular disease</span> Class of diseases that involve the heart or blood vessels

Cardiovascular disease (CVD) is any disease involving the heart or blood vessels. CVDs constitute a class of diseases that includes: coronary artery diseases, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.

The Dietary Approaches to Stop Hypertension or the DASH diet is a diet to control hypertension promoted by the U.S.-based National Heart, Lung, and Blood Institute, part of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services. The DASH diet is rich in fruits, vegetables, whole grains, and low-fat dairy foods. It includes meat, fish, poultry, nuts, and beans, and is limited in sugar-sweetened foods and beverages, red meat, and added fats. In addition to its effect on blood pressure, it is designed to be a well-balanced approach to eating for the general public. DASH is recommended by the United States Department of Agriculture (USDA) as a healthy eating plan. The DASH diet is one of three healthy diets recommended in the 2015–20 U.S. Dietary Guidelines, which also include the Mediterranean diet and a vegetarian diet. The American Heart Association (AHA) considers the DASH diet "specific and well-documented across age, sex and ethnically diverse groups."

The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) is a cardiology research group founded as a collaboration between two Italian organisations – the Mario Negri Institute for Pharmacological Research and the Associazione Nazionale dei Medici Cardiologi Ospedalieri (ANMCO).

<span class="mw-page-title-main">Valentín Fuster</span> Spanish cardiologist (born 1943)

Valentín Fuster Carulla, 1st Marquess of Fuster is a Spanish cardiologist and aristocrat.

<span class="mw-page-title-main">Myocardial infarction</span> Interruption of cardiac blood supply

A myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops in one of the coronary arteries of the heart, causing infarction to the heart muscle. The most common symptom is retrosternal chest pain or discomfort that classically radiates to the left shoulder, arm, or jaw. The pain may occasionally feel like heartburn.

Polycap is a specific five-in-one fixed dose combination polypill created by Cadila Pharmaceuticals Limited of Ahmedabad, India that combines moderate levels of five different medications in a single, one-a-day pill aimed at reducing/preventing heart attacks and strokes.

On October 25, 2007, the Minister of Health announced that the Government of Canada would establish an expert Sodium Working Group to explore options for reducing sodium intake and cardiovascular disease among Canadians.

A health claim found on a food labels and in food marketing is a claim by a food manufacturer that their product will reduce the risk of developing a disease or condition.

Ronald M. Krauss is an American professor of pediatrics, medical researcher and low-carbohydrate diet advocate. He studies genetic, dietary, and hormonal effects on plasma lipoproteins and coronary disease risk.

<span class="mw-page-title-main">Philip Poole-Wilson</span>

Philip Alexander Poole-Wilson FRCP, FESC, FACC, FMedSci was a British academic cardiologist of international reputation who had particular interest in the management of heart failure. His research helped to identify the cellular mechanisms behind heart failure and was also important in improving treatment for patients. He was instrumental in raising the profile of heart failure as a major public health problem.

Peter Sleight was a British research cardiologist and an Honorary Consultant Physician at the John Radcliffe Hospital in Oxford and the Oxford University Hospitals NHS Foundation Trust. Sleight was Emeritus Field Marshal Alexander Professor of Cardiovascular Medicine at the University of Oxford and an Emeritus Fellow of Exeter College, Oxford.

Bongani Mawethu Mayosi BMedSci, MB ChB, FCP(SA), DPhil, was a South African professor of cardiology He was the Dean of the Faculty of Health Sciences at the University of Cape Town and an A-rated National Research Foundation researcher. Prior to this, he was head of the Department of Medicine at the University of Cape Town and Groote Schuur Hospital. his research interests included rheumatic fever, tuberculous pericarditis and cardiomyopathy. He was a member of the Academy of Science of South Africa and a former President of the College of Physicians of South Africa and he headed numerous other biomedical organisations during his career.

<span class="mw-page-title-main">Sonia Anand</span> Canadian medical scientist

Sonia Savitri Anand is a Canadian vascular medicine specialist. She previously held the Eli Lilly Canada - May Cohen Chair in Women's Health and currently holds the Michael DeGroote Heart and Stroke Chair in Population Health and Epidemiology at McMaster University.

Lionel Henry Opie was a South African cardiologist. He was a professor of medicine at the University of Cape Town, where he conducted both experimental and clinical research on heart disease and cardiovascular physiology, metabolism, and pharmacology. He was the founding director of the university's Hatter Institute for Cardiovascular Research and the founding editor of the Journal of Molecular and Cellular Cardiology. He also served as president of the International Society for Heart Research.

References

  1. 1 2 3 4 5 6 7 "Dr. Salim Yusuf". Canadian Medical Hall of Fame. 2014.
  2. 1 2 3 4 5 6 Lane, Richard (August 2015). "Salim Yusuf: global leader in cardiovascular disease research". The Lancet. 386 (9994): 645. doi:10.1016/s0140-6736(15)61492-1. ISSN   0140-6736.
  3. 1 2 3 "Leaders in cardiovascular medicine Salim Yusuf MD: the physician who wants to improve the world's cardiovascular health". European Heart Journal. 36 (25): 1560–1565. 1 July 2015. doi:10.1093/eurheartj/ehv148. ISSN   0195-668X.
  4. ↑ Yusuf, Salim (1980). Yusuf, Salim, (1980). Beta adrenergic blokade in myocardial infarction. DPhil. University of Oxford. Oxford Research Archive (Thesis). University of Oxford.
  5. 1 2 Semeniuk, Ivan (26 March 2014). "Canada's Salim Yusuf wins prestigious Gairdner award". Globe and Mail.
  6. ↑ "History". PHRI. Retrieved 17 June 2018.
  7. ↑ Yusuf, Salim; Hawken, Steven; Ôunpuu, Stephanie; Dans, Tony; Avezum, Alvaro; Lanas, Fernando; McQueen, Matthew; Budaj, Andrzej; Pais, Prem; Varigos, John; Lisheng, Liu (September 2004). "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study". The Lancet. 364 (9438): 937–952. doi:10.1016/S0140-6736(04)17018-9.
  8. ↑ "Our History". World Heart Federation. Retrieved 18 June 2018.
  9. ↑ "Professor Salim Yusuf". sjc.ox.ac.uk. Retrieved 13 October 2023.
  10. ↑ "Is It Time to Loosen Restrictions on Saturated Fats and Salt?". tctmd.com. Retrieved 13 October 2023.
  11. 1 2 3 4 Phend, Crystal (2 March 2017). "Fat Wars: Diet Docs Have Salim Yusuf in the Cross Hairs". MedPage Today.
  12. ↑ "The more carbs you eat, the higher the risk of heart disease, states leading cardiologist, Dr Salim Yusuf". diabetes.co.uk. Retrieved 3 December 2022.
  13. ↑ American Heart Association strongly refutes study findings on sodium consumption. newsroom.heart.org. Retrieved 3 December 2022.
  14. 1 2 Dunphy, Siobhán (10 August 2018). "Yet another controversial study claiming salt may not be as bad as once thought". European Scientist. Retrieved 10 October 2024.
  15. ↑ "Professor named to Order of Canada". McMaster University. 2 July 2013.
  16. ↑ "Honorary degree recipients for 2024 announced | University of Oxford". www.ox.ac.uk. 24 April 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.